Predetermined Change Control Plans are central to FDA oversight of AI/ML medical devices. Learn why proving algorithm changes with cryptographic evidence is bec
The Predetermined Change Control Plan (PCCP) is one of the most consequential regulatory innovations for AI/ML-based medical devices. FDA recognized that traditional device modification pathways (supplemental 510(k) or PMA supplement for every change) are impractical for AI devices that are designed to improve over time. The PCCP framework allows manufacturers to describe, in advance, the types of changes their algorithm will undergo, the methods they will use to control those changes, and the performance criteria that will govern whether a change is acceptable.
In theory, this gives AI device manufacturers a pathway to update their algorithms without filing a new submission for every modification. In practice, PCCP compliance creates a documentation challenge that most manufacturers are not equipped to handle.
A PCCP requires the manufacturer to document every algorithm change, demonstrate that the change falls within the pre-specified modification protocol, provide evidence that validation testing was performed using the approved methodology, show that post-change performance meets the pre-defined acceptance criteria, and maintain records that allow FDA to verify compliance at any future inspection. The challenge is that "document" and "demonstrate" and "provide evidence" all imply verifiability. When FDA reviews a PCCP during an inspection, they are not looking for a narrative description of what happened. They want evidence that the documented process was actually followed, with records that cannot have been fabricated or altered after the fact.
This is where most AI device manufacturers encounter a gap. Their change control documentation lives in project management tools, version control systems, and internal wikis. These systems are excellent for managing development workflows, but they produce records that are fundamentally mutable. An investigator examining PCCP compliance needs to trust that the documented validation results correspond to the actual model that was deployed, that the deployment dates are accurate, and that no intermediate versions were deployed without proper change control. Mutable records cannot provide that trust.
Cryptographic decision records address the PCCP documentation gap by creating a tamper-evident chain of every algorithm change event. When a model is retrained, the new model binary hash, training data fingerprint, and validation results are sealed into the decision chain before the model is deployed. When performance thresholds are adjusted, the old and new threshold values are recorded with cryptographic timestamps. When validation testing is performed, the test results are sealed with the specific model version they evaluated.
This creates a complete, verifiable history of every algorithm modification that FDA can audit with confidence. The cryptographic guarantees mean investigators do not need to rely on organizational controls or access policies to trust the records. The mathematics of the cryptographic chain provide the assurance directly.
While regulatory compliance is the primary driver for PCCP evidence infrastructure, the operational benefits are substantial. Development teams gain a reliable record of which model version was deployed at any point in time, simplifying debugging and performance analysis. Quality teams can verify that change control procedures were followed without manually auditing development artifacts. And regulatory affairs teams can prepare submission supplements and annual reports using verified data rather than reconstructed narratives. The infrastructure that satisfies FDA also improves the organization's own understanding of its AI device lifecycle.